Sawyer & Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sawyer & Company’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300	Closed	-$6K	–	196
2023 Q3	$6K	Buy	+300	New	+$3.39K	﹤0.01%	172

Sawyer & Company's ICPT Position: Q4 2023 in Review

Sawyer & Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 300 shares — an estimated $6K sold.

Sawyer & Company first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $6K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Sawyer & Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Sawyer & Company sold 300 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6K.
Sawyer & Company first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
Sawyer & Company's Intercept Pharmaceuticals, Inc. position peaked at $6K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Sawyer & Company's 13F filing for Q4 2023, filed 17 Jan 2024.